Dr. Barbara Ann Schultz, MD

Dr. Schultz practices at University of Texas Southwestern Medical Center at Dallas in Dallas, Texas.

Dr. Schultz's NPI, 1235226648, was assigned on October 6, 2006. Dr. Schultz graduated from UT Southwestern Medical Center in 1980. Dr. Schultz holds Texas license F7149.

Dr. Schultz's primary practice is University of Texas Southwestern Medical Center at Dallas, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Schultz's primary practice is University of Texas Southwestern Medical Center at Dallas in Dallas, Texas. Dr. Schultz is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Schultz to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Schultz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Schultz is licensed in Texas.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and tinnitus among the conditions Dr. Schultz treats.

CMS data shows 121 Medicare services from Dr. Schultz across 5 procedure codes in 2024, for 111 Medicare patients. Medicare paid $7,488 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Dr. Schultz in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 65, with 62% women.

In 2024, Dr. Schultz wrote 43 Medicare Part D claims for 19 patients. 70% of them were for generic drugs. They cover 2 drugs, with $2,248 in total drug cost. In 2021, CMS named 55 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Schultz for performance year 2024, reported as part of a group. Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Schultz in 2020. Dr. Schultz's most frequent co-authors are Simone Arvisais-Anhalt, MD, Justin Avery Bishop, MD and Andrew T. Day, MD.

CMS Open Payments shows 8 general payments to Dr. Schultz from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. ALK-Abello, Inc paid the most, $139.

Dmand AI lists 4 awards for Dr. Schultz, most recently CMS Stage 1 EHR in 2012.

Dr. Schultz graduated from UT Southwestern Medical Center in 1980. Dr. Schultz is a member of NHS.

Dr. Schultz is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.